ROTHSCHILD & CO ASSET MANAGEMENT US INC. – Revance Therapeutics, Inc. Transaction History
ROTHSCHILD & CO ASSET MANAGEMENT US INC. portfolio value:
$5.80M
portfolio value
ROTHSCHILD & CO ASSET MANAGEMENT US INC. quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.71% | -1.53K shares | 2.81M | $27 | 214.93K |
| Q2 2022 | share | Decrease | -2.67% | -5.93K shares | -1.34M | $13.82 | 216.47K |
| Q1 2022 | share | Decrease | -23.08% | -66.71K shares | -382K | $19.5 | 222.40K |
| Q4 2021 | share | Decrease | -4.98% | -15.14K shares | -3.75M | $16.49 | 289.12K |
| Q3 2021 | share | Decrease | -11.81% | -40.75K shares | -1.75M | $27.86 | 304.27K |
| Q2 2021 | share | Decrease | -10.11% | -38.79K shares | -501K | $29.64 | 345.03K |
| Q1 2021 | share | Decrease | -10.70% | -46.00K shares | -1.45M | $27.95 | 383.82K |
| Q4 2020 | share | Decrease | -1.94% | -8.48K shares | 1.16M | $28.34 | 429.83K |
| Q3 2020 | share | Decrease | -9.36% | -45.25K shares | -790K | $25.14 | 438.32K |
| Q2 2020 | share | Increase | +0.67% | 3.20K shares | 4.7M | $24.42 | 483.57K |
| Q1 2020 | share | Decrease | -14.18% | -79.39K shares | -1.97M | $14.8 | 480.36K |
| Q4 2019 | share | Increase | +1496.73% | 524.70K shares | 8.62M | $16.23 | 559.76K |
| Q3 2019 | share | Increase | +27.85% | 7.63K shares | 100K | $13 | 35.05K |
| Q2 2019 | share | Decrease | -1.05% | -291 shares | -81K | $12.97 | 27.42K |
| Q1 2019 | share | Decrease | -43.95% | -21.72K shares | -558K | $15.76 | 27.71K |
| Q4 2018 | share | Increase | +1.21% | 590 shares | -219K | $20.13 | 49.44K |
| Q3 2018 | share | Increase | 0.00% | 48.85K shares | 1.21M | $24.85 | 48.85K |
| Q2 2018 | share | Decrease | -6.58% | -2.92K shares | -229K | $27.45 | 41.55K |
| Q1 2018 | share | Decrease | -9.78% | -4.82K shares | -393K | $30.8 | 44.47K |
| Q4 2017 | share | Decrease | -6.99% | -3.70K shares | 303K | $35.75 | 49.30K |
| Q3 2017 | share | Decrease | -2.14% | -1.15K shares | 30K | $27.55 | 53.00K |
| Q2 2017 | share | Decrease | -4.32% | -2.44K shares | 253K | $26.4 | 54.16K |
| Q1 2017 | share | Decrease | -6.87% | -4.17K shares | -81K | $20.8 | 56.61K |
| Q4 2016 | share | Increase | +462.42% | 49.97K shares | 1.08M | $20.7 | 60.78K |
| Q3 2016 | share | Increase | +2.55% | 269 shares | 32K | $16.21 | 10.80K |
| Q2 2016 | share | Increase | 0.00% | 10.53K shares | 143K | $13.6 | 10.53K |